Found 9 matching trials
High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia
NAThis pilot clinical trial studies the feasibility of choosing treatment bas...
Location
Fred Hutch/University of Washington Cancer Consortium
Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma
PHASE2Background:
Advanced urothelial cancer has no cure. But only a few chemoth...
Location
National Institutes of Health Clinical Center
A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema
PHASE1A Phase I Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pan...
Location
Brown University Oncology Research Group
BrUOG-PA-209: Lapatinib and Gemcitabine for Metastatic Pancreaticobiliary Cancer
PHASE1Phase I study of lapatinib and gemcitabine for patients with metastatic pan...
Location
Lifespan Hospitals
Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment.
PHASE2Despite these initial positive signals in recent statistics, breast cancer ...
Location
Dr. Guillermo Lerzo
Chemotherapeutic Agents in Brain/Breast
N/ARATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Location
Memorial Sloan Kettering
Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents
PHASE1This study is designed to provide continued access to lapatinib as monother...
Location
Novartis Investigative Site
Lapatinib, Cisplatin, Gemcitabine as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urothelial Cancer
PHASE1RATIONALE: Lapatinib may stop the growth of tumor cells by blocking some of...
Location
Rigshospitalet - Copenhagen University Hospital
Preoperative Chemotherapy With Paclitaxel, Gemcitabine, and Lapatinib (Tykerb®) (PGT)
PHASE1Primary objectives :
1\. To evaluate the recommended dose of the combinati...
Location
National Cancer Center